Clinical Trials Directory

Trials / Completed

CompletedNCT06463509

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced Melanoma - a Prospective, Multicentric HFV Research Project/Category A

Status
Completed
Phase
Study type
Observational
Enrollment
116 (actual)
Sponsor
Reinhard Dummer · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

TUPRO-Melanoma is the first project of the Tumour Profiler (TUPRO) research collaboration, which in the long-term aims to generate data that will help to understand and report the individual tumour biology and the clinical parameters for patients with advanced malignancies using innovative molecular technologies and computational analyses for in-depth molecular profiling. TUPRO-Melanoma is an exploratory project that aims to establish a comprehensive platform for in-depth tumour profiling in patients suffering from advanced melanoma. Aims of this platform are to establish logistics and algorithms for integrative analyses and discover new molecular biomarker profiles/patterns.

Conditions

Interventions

TypeNameDescription
OTHEREstablishment of an in-deepth tumor profiling platformIn-depth tumor profiling beyond genomics

Timeline

Start date
2019-01-08
Primary completion
2023-05-31
Completion
2023-05-31
First posted
2024-06-17
Last updated
2024-06-17

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06463509. Inclusion in this directory is not an endorsement.

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma (NCT06463509) · Clinical Trials Directory